Pregnancy & Non-Communicable Diseases Committee
Duration: 2017 - 2021
Chaired by Moshe Hod, Israel
Rachel Gooden, Project Coordinator
What are NCDs?
It is projected that by 2030, non-communicable diseases (NCDs) will claim 52 million
An NCD is a medical condition or disease that is not infectious or transmissible.
NCDs - also known as chronic diseases - can last for long periods of time and
progress slowly. The main types are: cardiovascular diseases (heart attacks,
strokes), cancers, chronic respiratory diseases and diabetes.
Almost 80% of these premature deaths will occur in low or low-middle income countries.
What is the relevance for pregnancy?
Undernutrition, overweight and obesity, hypertension, and hyperglycaemia are NCDs commonly associated with pregnancy and they can lead to considerable maternal morbidity and mortality, poor pregnancy outcomes, and detrimental effects on the offspring.
To improve both the short-term outcomes and long-term population health, NCDs must be addressed simultaneously alongside maternal health. Pregnancy provides a unique opportunity for prevention and management of NCDs for mother and child.
By establishing the Pregnancy & Non-Communicable Diseases Committee, FIGO is committing to advocate internationally on the importance of addressing pregnancy and NCDs.
Focusing on obesity and malnutrition, hyperglycemia and hypertension in pregnancy (HIP), the Committee will work through four streams:
- Advocacy, awareness, communication and health economics
- Training and capacity
- Best clinical management and advice
Maternal and child health is inextricably linked with non-communicable diseases.
The first Global Week for Action on non-communicable diseases (NCDs), 3-9 September, 2018 in the lead-up to the third High-level Meeting on the prevention and control of NCDs during the UN General Assembly, provided FIGO member societies with the opportunity to call out for the addition of vital language on maternal health in the upcoming UN resolution on prevention and control of NCDs.
World Diabetes Day
On 14 November each year, FIGO joins the international community for World Diabetes Day, to raise awareness of diabetes globally.
The day was launched in 1991 by the International Diabetes Federation and the World Health Organization, in response to growing concerns about the escalating health threat posed by diabetes.
Dr Moshe Hod, Israel - Chair
Dr Hema Divakar, India – Co Chair
Professor Mark Hanson, UK – Co Chair
Dr Anil Kapur, India
Dr David McIntyre, Australia
Dr Mary D’Alton, USA
Dr Anne Beatrice Kihara, Kenya
Dr Ronald Ma, Hong Kong
Professor Fionnuala McAuliffe, Ireland
Dr Christine Tippett – Ex officio